Kyphon strengthens international presence with new Swiss unit:
This article was originally published in Clinica
Executive Summary
Kyphon, the Sunnyvale, California-based balloon kyphoplasty specialist, has set up a new Swiss operation in order to accommodate its rapidly expanding international business and increase the firm's manufacturing capacity. Kyphon Sarl, based in Neuchatel, has begun administrative operations and is expected to have full manufacturing, distribution and R&D activities running by the end of 2007. Kyphon's international revenues soared 87% in 2005 compared to the previous year. Around 19% of the company's turnover in the fourth quarter of 2005 was attributed to international sales.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.